| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nutritional Sciences | 9 | 2021 | 68 | 2.690 |
Why?
|
| Nutritional Requirements | 15 | 2016 | 185 | 1.500 |
Why?
|
| Amino Acids | 38 | 2008 | 728 | 1.370 |
Why?
|
| Nutrition Policy | 8 | 2021 | 111 | 1.370 |
Why?
|
| Leucine | 42 | 2016 | 352 | 1.360 |
Why?
|
| Dietary Fats | 9 | 2021 | 339 | 1.320 |
Why?
|
| Diet | 23 | 2023 | 1440 | 1.080 |
Why?
|
| Diet, Mediterranean | 2 | 2023 | 14 | 1.050 |
Why?
|
| Recommended Dietary Allowances | 3 | 2020 | 24 | 0.780 |
Why?
|
| Dietary Sugars | 1 | 2020 | 18 | 0.770 |
Why?
|
| Taste | 1 | 2020 | 50 | 0.770 |
Why?
|
| Health | 4 | 2021 | 54 | 0.770 |
Why?
|
| Energy Metabolism | 15 | 2008 | 992 | 0.760 |
Why?
|
| Periodicals as Topic | 8 | 2018 | 338 | 0.730 |
Why?
|
| Energy Intake | 13 | 2021 | 515 | 0.710 |
Why?
|
| Growth Hormone | 12 | 1996 | 226 | 0.700 |
Why?
|
| Fatty Acids | 6 | 2020 | 448 | 0.680 |
Why?
|
| Nutritional Physiological Phenomena | 9 | 2016 | 101 | 0.630 |
Why?
|
| Journalism, Medical | 1 | 2017 | 11 | 0.620 |
Why?
|
| Biochemistry | 1 | 2017 | 24 | 0.620 |
Why?
|
| Insulin | 42 | 2008 | 1454 | 0.580 |
Why?
|
| Muscles | 13 | 1996 | 416 | 0.570 |
Why?
|
| Proteins | 23 | 2008 | 1963 | 0.560 |
Why?
|
| Phenylalanine | 7 | 2021 | 142 | 0.520 |
Why?
|
| Gluconeogenesis | 13 | 2005 | 121 | 0.520 |
Why?
|
| Glucose | 32 | 2008 | 1248 | 0.520 |
Why?
|
| Research Design | 6 | 2021 | 1544 | 0.510 |
Why?
|
| Adaptation, Physiological | 4 | 2008 | 360 | 0.490 |
Why?
|
| Health Promotion | 4 | 2017 | 502 | 0.480 |
Why?
|
| Alanine | 25 | 1997 | 240 | 0.480 |
Why?
|
| Blood Glucose | 49 | 2008 | 1244 | 0.480 |
Why?
|
| Food Safety | 2 | 2013 | 7 | 0.460 |
Why?
|
| Infant Food | 2 | 2012 | 89 | 0.440 |
Why?
|
| Exercise | 6 | 2022 | 1183 | 0.430 |
Why?
|
| Publishing | 5 | 2015 | 220 | 0.430 |
Why?
|
| Dietary Supplements | 6 | 2021 | 558 | 0.420 |
Why?
|
| Cardiovascular Diseases | 4 | 2020 | 2195 | 0.420 |
Why?
|
| Obesity | 15 | 2023 | 2884 | 0.410 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2021 | 2594 | 0.400 |
Why?
|
| Muscle Proteins | 7 | 1995 | 549 | 0.390 |
Why?
|
| Kinetics | 48 | 2005 | 2049 | 0.390 |
Why?
|
| Infant, Newborn | 18 | 2008 | 8223 | 0.390 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 16 | 1997 | 95 | 0.390 |
Why?
|
| Ketone Bodies | 12 | 1993 | 56 | 0.380 |
Why?
|
| Models, Biological | 17 | 2008 | 3254 | 0.380 |
Why?
|
| Child Nutrition Sciences | 1 | 2010 | 18 | 0.380 |
Why?
|
| Infant Nutritional Physiological Phenomena | 2 | 2012 | 182 | 0.380 |
Why?
|
| Isotope Labeling | 14 | 1997 | 142 | 0.380 |
Why?
|
| Nitrogen | 22 | 1996 | 162 | 0.370 |
Why?
|
| Epinephrine | 9 | 1993 | 255 | 0.360 |
Why?
|
| Dietary Carbohydrates | 5 | 2008 | 134 | 0.350 |
Why?
|
| Humans | 193 | 2023 | 261506 | 0.350 |
Why?
|
| Diffusion of Innovation | 1 | 2010 | 160 | 0.340 |
Why?
|
| Fetal Development | 2 | 2007 | 120 | 0.340 |
Why?
|
| Glutamine | 8 | 1997 | 299 | 0.330 |
Why?
|
| Lipolysis | 7 | 2001 | 108 | 0.330 |
Why?
|
| Nutrition Assessment | 2 | 2021 | 169 | 0.320 |
Why?
|
| Disease | 2 | 2007 | 165 | 0.320 |
Why?
|
| Lysine | 11 | 2020 | 422 | 0.310 |
Why?
|
| Nutritional Status | 5 | 2017 | 337 | 0.310 |
Why?
|
| Food | 6 | 2023 | 146 | 0.310 |
Why?
|
| Growth | 1 | 2008 | 117 | 0.300 |
Why?
|
| Insulin-Like Growth Factor I | 7 | 1996 | 630 | 0.290 |
Why?
|
| Conflict of Interest | 1 | 2007 | 98 | 0.290 |
Why?
|
| Practice Guidelines as Topic | 3 | 2021 | 2403 | 0.290 |
Why?
|
| Editorial Policies | 1 | 2007 | 87 | 0.280 |
Why?
|
| Lactates | 15 | 1995 | 112 | 0.280 |
Why?
|
| Glucagon | 19 | 1997 | 196 | 0.280 |
Why?
|
| Hydrocortisone | 8 | 1994 | 388 | 0.280 |
Why?
|
| Dietary Proteins | 15 | 1993 | 241 | 0.280 |
Why?
|
| Glycine | 12 | 1995 | 289 | 0.270 |
Why?
|
| Child Development | 1 | 2008 | 255 | 0.270 |
Why?
|
| Physical Exertion | 4 | 1993 | 113 | 0.260 |
Why?
|
| Aging | 8 | 2013 | 1582 | 0.250 |
Why?
|
| Tryptophan | 2 | 2016 | 127 | 0.250 |
Why?
|
| Isotopes | 6 | 1987 | 32 | 0.240 |
Why?
|
| Histidine | 2 | 2020 | 91 | 0.240 |
Why?
|
| United States | 8 | 2023 | 15433 | 0.240 |
Why?
|
| Hydroxybutyrates | 15 | 1992 | 44 | 0.230 |
Why?
|
| Muscle Development | 2 | 1995 | 88 | 0.230 |
Why?
|
| Fatty Acids, Nonesterified | 21 | 1997 | 159 | 0.220 |
Why?
|
| Weight Lifting | 2 | 1993 | 10 | 0.220 |
Why?
|
| Glucose Tolerance Test | 15 | 2008 | 213 | 0.220 |
Why?
|
| Serine | 3 | 2021 | 388 | 0.220 |
Why?
|
| Carbon Isotopes | 26 | 1999 | 333 | 0.220 |
Why?
|
| Insulin Resistance | 8 | 2008 | 731 | 0.220 |
Why?
|
| Body Height | 5 | 2008 | 231 | 0.220 |
Why?
|
| Fast Foods | 1 | 2022 | 31 | 0.210 |
Why?
|
| Needs Assessment | 2 | 2013 | 233 | 0.210 |
Why?
|
| Iodides | 2 | 1998 | 14 | 0.200 |
Why?
|
| Nitrogen Isotopes | 18 | 1995 | 60 | 0.200 |
Why?
|
| Infant | 22 | 2020 | 13310 | 0.200 |
Why?
|
| Spectrophotometry | 2 | 1998 | 82 | 0.200 |
Why?
|
| Infant, Premature | 5 | 1995 | 787 | 0.200 |
Why?
|
| Palmitic Acid | 5 | 2016 | 42 | 0.190 |
Why?
|
| Tyrosine | 4 | 1995 | 498 | 0.190 |
Why?
|
| Public Health | 2 | 2013 | 299 | 0.190 |
Why?
|
| Child Welfare | 1 | 2000 | 66 | 0.190 |
Why?
|
| Phenylalanine Hydroxylase | 2 | 1995 | 25 | 0.190 |
Why?
|
| Beverages | 1 | 2020 | 105 | 0.180 |
Why?
|
| Food, Fortified | 1 | 2020 | 95 | 0.180 |
Why?
|
| Methionine | 1 | 2020 | 159 | 0.180 |
Why?
|
| Life Style | 3 | 2017 | 612 | 0.180 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 1998 | 548 | 0.180 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2000 | 174 | 0.170 |
Why?
|
| Reference Values | 15 | 2020 | 1099 | 0.170 |
Why?
|
| Male | 116 | 2021 | 123000 | 0.170 |
Why?
|
| Deuterium | 14 | 1999 | 111 | 0.170 |
Why?
|
| Adult | 94 | 2021 | 77950 | 0.170 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1999 | 140 | 0.170 |
Why?
|
| Autoanalysis | 1 | 1998 | 7 | 0.160 |
Why?
|
| Glycerol | 14 | 1999 | 99 | 0.160 |
Why?
|
| Infant, Low Birth Weight | 1 | 1999 | 181 | 0.160 |
Why?
|
| Weight Loss | 1 | 2022 | 627 | 0.160 |
Why?
|
| Cardiovascular System | 1 | 2020 | 145 | 0.160 |
Why?
|
| Infusions, Intravenous | 11 | 2003 | 1382 | 0.160 |
Why?
|
| History, 21st Century | 2 | 2017 | 441 | 0.160 |
Why?
|
| Nutritive Value | 3 | 2016 | 96 | 0.160 |
Why?
|
| Apolipoproteins B | 6 | 1995 | 106 | 0.160 |
Why?
|
| Glutamates | 3 | 1997 | 130 | 0.150 |
Why?
|
| Body Composition | 8 | 2003 | 595 | 0.150 |
Why?
|
| Iodine | 1 | 1998 | 54 | 0.150 |
Why?
|
| Lipoproteins | 2 | 2016 | 252 | 0.150 |
Why?
|
| Mass Spectrometry | 11 | 1992 | 702 | 0.150 |
Why?
|
| Lipid Metabolism | 6 | 2008 | 483 | 0.150 |
Why?
|
| Europe | 1 | 2018 | 649 | 0.140 |
Why?
|
| Metabolism | 2 | 2005 | 55 | 0.140 |
Why?
|
| Oxygen Isotopes | 3 | 1992 | 36 | 0.140 |
Why?
|
| Feeding Behavior | 4 | 2014 | 808 | 0.140 |
Why?
|
| Hippurates | 2 | 1995 | 4 | 0.130 |
Why?
|
| Burns | 4 | 1986 | 117 | 0.130 |
Why?
|
| Somatostatin | 5 | 1990 | 114 | 0.130 |
Why?
|
| Cholesterol, HDL | 1 | 2016 | 341 | 0.130 |
Why?
|
| History, 20th Century | 1 | 2017 | 574 | 0.130 |
Why?
|
| Keto Acids | 6 | 1993 | 59 | 0.120 |
Why?
|
| Biomedical Research | 2 | 2013 | 806 | 0.120 |
Why?
|
| Isoleucine | 3 | 1986 | 29 | 0.120 |
Why?
|
| Chronic Disease | 2 | 2016 | 1819 | 0.120 |
Why?
|
| Interdisciplinary Studies | 1 | 2013 | 7 | 0.120 |
Why?
|
| Congresses as Topic | 3 | 2014 | 298 | 0.120 |
Why?
|
| Methylhistidines | 4 | 1995 | 10 | 0.120 |
Why?
|
| Cystic Fibrosis | 1 | 1996 | 264 | 0.120 |
Why?
|
| Health Priorities | 1 | 2013 | 40 | 0.120 |
Why?
|
| Oxidation-Reduction | 18 | 2005 | 717 | 0.110 |
Why?
|
| Arginine | 1 | 2016 | 500 | 0.110 |
Why?
|
| Theophylline | 1 | 1992 | 34 | 0.110 |
Why?
|
| Osmolar Concentration | 6 | 1998 | 204 | 0.110 |
Why?
|
| Calcium Isotopes | 1 | 1992 | 8 | 0.110 |
Why?
|
| Intracellular Fluid | 3 | 1988 | 45 | 0.110 |
Why?
|
| C-Peptide | 8 | 2008 | 107 | 0.110 |
Why?
|
| Cholesterol, LDL | 1 | 2016 | 565 | 0.110 |
Why?
|
| Food Additives | 1 | 2012 | 5 | 0.110 |
Why?
|
| United States Department of Agriculture | 1 | 2012 | 9 | 0.110 |
Why?
|
| Legislation, Food | 1 | 2012 | 4 | 0.110 |
Why?
|
| Stroke | 2 | 2020 | 1144 | 0.110 |
Why?
|
| Food Contamination | 1 | 2012 | 22 | 0.110 |
Why?
|
| Cluster Analysis | 1 | 2015 | 1053 | 0.110 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 1993 | 208 | 0.110 |
Why?
|
| Rats | 8 | 2012 | 6086 | 0.110 |
Why?
|
| Body Weight | 6 | 2021 | 1293 | 0.110 |
Why?
|
| Child, Preschool | 20 | 2008 | 16273 | 0.110 |
Why?
|
| Amino Acids, Essential | 3 | 2008 | 26 | 0.110 |
Why?
|
| Causality | 2 | 2022 | 178 | 0.100 |
Why?
|
| Administration, Oral | 4 | 2021 | 1544 | 0.100 |
Why?
|
| Infusions, Parenteral | 15 | 1986 | 191 | 0.100 |
Why?
|
| Infant Formula | 1 | 2012 | 91 | 0.100 |
Why?
|
| Female | 68 | 2021 | 141928 | 0.100 |
Why?
|
| Pediatrics | 5 | 2010 | 1141 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2012 | 2063 | 0.100 |
Why?
|
| Nutrition Disorders | 1 | 1991 | 57 | 0.100 |
Why?
|
| United States Food and Drug Administration | 1 | 2012 | 332 | 0.100 |
Why?
|
| Acetoacetates | 7 | 1993 | 20 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 1996 | 1362 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 1 | 8 | 1993 | 830 | 0.090 |
Why?
|
| Palmitic Acids | 7 | 1993 | 19 | 0.090 |
Why?
|
| Hydroxybutyrate Dehydrogenase | 1 | 1989 | 5 | 0.090 |
Why?
|
| Lipoproteins, VLDL | 5 | 1995 | 89 | 0.090 |
Why?
|
| Research Subjects | 1 | 2010 | 65 | 0.090 |
Why?
|
| Growth Disorders | 5 | 1992 | 218 | 0.090 |
Why?
|
| Child | 26 | 2007 | 29154 | 0.090 |
Why?
|
| Fructose | 2 | 2008 | 72 | 0.090 |
Why?
|
| Biological Transport | 9 | 1996 | 597 | 0.090 |
Why?
|
| Basal Metabolism | 1 | 1989 | 88 | 0.090 |
Why?
|
| Time Factors | 14 | 2008 | 12926 | 0.090 |
Why?
|
| Risk Factors | 6 | 2020 | 17523 | 0.080 |
Why?
|
| Diabetes Mellitus | 5 | 1989 | 1054 | 0.080 |
Why?
|
| Canada | 2 | 2021 | 429 | 0.080 |
Why?
|
| Carbon Dioxide | 8 | 1993 | 313 | 0.080 |
Why?
|
| Chromatography, Gas | 6 | 1992 | 39 | 0.080 |
Why?
|
| Insulin-Secreting Cells | 1 | 2008 | 154 | 0.070 |
Why?
|
| Feedback, Physiological | 1 | 2008 | 193 | 0.070 |
Why?
|
| Body Fluids | 1 | 1988 | 125 | 0.070 |
Why?
|
| Academic Medical Centers | 1 | 2010 | 672 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2014 | 1209 | 0.070 |
Why?
|
| Carbon Radioisotopes | 7 | 1996 | 116 | 0.070 |
Why?
|
| Liver | 10 | 1993 | 2961 | 0.070 |
Why?
|
| Adrenocortical Hyperfunction | 1 | 1986 | 7 | 0.070 |
Why?
|
| 3-Hydroxybutyric Acid | 6 | 1992 | 32 | 0.070 |
Why?
|
| Recombinant Proteins | 6 | 1995 | 2927 | 0.070 |
Why?
|
| Amino Acids, Branched-Chain | 7 | 1987 | 94 | 0.070 |
Why?
|
| Fasting | 7 | 1989 | 349 | 0.070 |
Why?
|
| Phenotype | 3 | 2008 | 6295 | 0.070 |
Why?
|
| Forearm | 8 | 1997 | 67 | 0.070 |
Why?
|
| Maple Syrup Urine Disease | 2 | 1985 | 15 | 0.060 |
Why?
|
| Kwashiorkor | 1 | 2005 | 40 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2016 | 4938 | 0.060 |
Why?
|
| Skin | 2 | 1988 | 1259 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2010 | 1085 | 0.060 |
Why?
|
| Animals | 20 | 2013 | 59536 | 0.060 |
Why?
|
| Nutrigenomics | 2 | 2013 | 11 | 0.060 |
Why?
|
| Embryonic and Fetal Development | 1 | 2004 | 205 | 0.060 |
Why?
|
| Islets of Langerhans | 3 | 1992 | 229 | 0.060 |
Why?
|
| Edema | 1 | 2005 | 267 | 0.060 |
Why?
|
| Hypoglycemia | 6 | 1983 | 213 | 0.060 |
Why?
|
| Food Preferences | 2 | 2013 | 119 | 0.050 |
Why?
|
| Food Handling | 1 | 2022 | 22 | 0.050 |
Why?
|
| Food Supply | 2 | 2013 | 97 | 0.050 |
Why?
|
| Lipoproteins, LDL | 3 | 1993 | 163 | 0.050 |
Why?
|
| Islets of Langerhans Transplantation | 2 | 1992 | 35 | 0.050 |
Why?
|
| Galactosemias | 1 | 1982 | 17 | 0.050 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2003 | 105 | 0.050 |
Why?
|
| Valine | 4 | 1986 | 176 | 0.050 |
Why?
|
| Galactose | 1 | 1982 | 87 | 0.050 |
Why?
|
| Metagenome | 2 | 2013 | 176 | 0.050 |
Why?
|
| Diseases in Twins | 2 | 1983 | 99 | 0.050 |
Why?
|
| Physical Endurance | 2 | 1993 | 58 | 0.050 |
Why?
|
| Antioxidants | 1 | 2005 | 507 | 0.050 |
Why?
|
| Mental Fatigue | 1 | 2021 | 5 | 0.050 |
Why?
|
| Adolescent | 23 | 2008 | 31252 | 0.050 |
Why?
|
| Muscle, Skeletal | 4 | 1996 | 1270 | 0.050 |
Why?
|
| Failure to Thrive | 1 | 2001 | 91 | 0.050 |
Why?
|
| Safety | 1 | 2003 | 465 | 0.050 |
Why?
|
| Choice Behavior | 2 | 2013 | 226 | 0.050 |
Why?
|
| Infant, Small for Gestational Age | 1 | 1981 | 59 | 0.050 |
Why?
|
| Dogs | 6 | 1993 | 1155 | 0.050 |
Why?
|
| Lactic Acid | 5 | 1995 | 305 | 0.050 |
Why?
|
| Heterozygote | 2 | 1992 | 1020 | 0.050 |
Why?
|
| Physical Education and Training | 3 | 1996 | 23 | 0.050 |
Why?
|
| Blood Pressure | 4 | 1996 | 1467 | 0.050 |
Why?
|
| Urea | 3 | 1988 | 290 | 0.050 |
Why?
|
| Checklist | 1 | 2021 | 122 | 0.050 |
Why?
|
| Uremia | 1 | 1980 | 42 | 0.050 |
Why?
|
| Research Report | 1 | 2021 | 144 | 0.050 |
Why?
|
| Fetus | 1 | 2004 | 601 | 0.050 |
Why?
|
| Fetal Diseases | 1 | 2004 | 388 | 0.050 |
Why?
|
| Dairy Products | 1 | 2020 | 38 | 0.050 |
Why?
|
| Quinoxalines | 1 | 1980 | 95 | 0.050 |
Why?
|
| Carbon | 4 | 1996 | 149 | 0.040 |
Why?
|
| Respiration | 4 | 2003 | 447 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2008 | 2086 | 0.040 |
Why?
|
| Norepinephrine | 6 | 1989 | 272 | 0.040 |
Why?
|
| Trace Elements | 3 | 1984 | 33 | 0.040 |
Why?
|
| Fetal Growth Retardation | 1 | 1980 | 194 | 0.040 |
Why?
|
| Intestinal Absorption | 4 | 1997 | 211 | 0.040 |
Why?
|
| Carbohydrate Metabolism | 4 | 1990 | 74 | 0.040 |
Why?
|
| Aged | 15 | 2016 | 70117 | 0.040 |
Why?
|
| Ammonium Sulfate | 1 | 1998 | 8 | 0.040 |
Why?
|
| Guidelines as Topic | 1 | 2000 | 383 | 0.040 |
Why?
|
| Injections, Subcutaneous | 2 | 1996 | 334 | 0.040 |
Why?
|
| Colorimetry | 1 | 1998 | 31 | 0.040 |
Why?
|
| Arsenites | 1 | 1998 | 18 | 0.040 |
Why?
|
| Sleep | 1 | 2021 | 413 | 0.040 |
Why?
|
| Body Water | 2 | 1992 | 132 | 0.040 |
Why?
|
| Lipodystrophy | 1 | 1978 | 44 | 0.040 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 1998 | 70 | 0.040 |
Why?
|
| Rats, Inbred Strains | 3 | 1986 | 410 | 0.040 |
Why?
|
| Oxygen Consumption | 4 | 2003 | 401 | 0.040 |
Why?
|
| Metabolic Clearance Rate | 6 | 1997 | 231 | 0.040 |
Why?
|
| Circadian Rhythm | 2 | 1992 | 330 | 0.040 |
Why?
|
| Microchemistry | 4 | 1986 | 11 | 0.040 |
Why?
|
| Eating | 2 | 1995 | 421 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 1998 | 4971 | 0.040 |
Why?
|
| Hot Temperature | 1 | 1998 | 281 | 0.040 |
Why?
|
| Prader-Willi Syndrome | 1 | 1977 | 69 | 0.040 |
Why?
|
| Research | 1 | 1999 | 415 | 0.040 |
Why?
|
| Transplantation, Heterotopic | 2 | 1992 | 43 | 0.030 |
Why?
|
| Iodine Radioisotopes | 1 | 1998 | 371 | 0.030 |
Why?
|
| Brain | 2 | 2008 | 4113 | 0.030 |
Why?
|
| Hormones | 4 | 1994 | 266 | 0.030 |
Why?
|
| Pregnancy | 7 | 2004 | 7573 | 0.030 |
Why?
|
| Glutamic Acid | 2 | 1988 | 309 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 1996 | 318 | 0.030 |
Why?
|
| Homeostasis | 2 | 1983 | 950 | 0.030 |
Why?
|
| Radioisotope Dilution Technique | 4 | 1996 | 46 | 0.030 |
Why?
|
| Epidemiologic Studies | 1 | 2014 | 60 | 0.030 |
Why?
|
| Global Health | 2 | 2013 | 657 | 0.030 |
Why?
|
| Tritium | 5 | 1996 | 200 | 0.030 |
Why?
|
| Acetonitriles | 1 | 1994 | 6 | 0.030 |
Why?
|
| Abnormalities, Multiple | 1 | 1980 | 998 | 0.030 |
Why?
|
| Myotonic Dystrophy | 1 | 1995 | 151 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2008 | 5539 | 0.030 |
Why?
|
| Indicators and Reagents | 1 | 1994 | 128 | 0.030 |
Why?
|
| Behavioral Research | 1 | 2013 | 23 | 0.030 |
Why?
|
| Bias | 1 | 2014 | 205 | 0.030 |
Why?
|
| Serum Albumin | 1 | 1994 | 257 | 0.030 |
Why?
|
| Societies, Scientific | 1 | 2013 | 74 | 0.030 |
Why?
|
| Fluorocarbons | 1 | 1994 | 63 | 0.030 |
Why?
|
| Birth Weight | 1 | 1995 | 374 | 0.030 |
Why?
|
| Anaerobic Threshold | 1 | 1992 | 11 | 0.030 |
Why?
|
| Acetyl Coenzyme A | 1 | 1993 | 23 | 0.030 |
Why?
|
| Nitrogen Radioisotopes | 2 | 1990 | 3 | 0.030 |
Why?
|
| Renal Dialysis | 1 | 1980 | 945 | 0.030 |
Why?
|
| Hypobetalipoproteinemias | 1 | 1992 | 2 | 0.030 |
Why?
|
| Mevalonic Acid | 1 | 1992 | 34 | 0.030 |
Why?
|
| Cross-Over Studies | 2 | 2005 | 460 | 0.030 |
Why?
|
| Kidney Diseases | 1 | 1978 | 691 | 0.030 |
Why?
|
| Clinical Trials as Topic | 2 | 2021 | 3719 | 0.030 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 1993 | 100 | 0.030 |
Why?
|
| Epigenomics | 1 | 2013 | 266 | 0.030 |
Why?
|
| Middle Aged | 19 | 2004 | 86204 | 0.030 |
Why?
|
| Protein Biosynthesis | 4 | 1993 | 889 | 0.030 |
Why?
|
| Spectrum Analysis | 2 | 1982 | 139 | 0.030 |
Why?
|
| Bicycling | 1 | 1991 | 38 | 0.030 |
Why?
|
| Gestational Age | 1 | 1995 | 1069 | 0.030 |
Why?
|
| Creatinine | 1 | 1993 | 531 | 0.020 |
Why?
|
| Adipose Tissue | 2 | 1992 | 769 | 0.020 |
Why?
|
| Fluorometry | 2 | 1989 | 34 | 0.020 |
Why?
|
| Cyclosporine | 1 | 1992 | 278 | 0.020 |
Why?
|
| Receptor, IGF Type 1 | 1 | 1992 | 347 | 0.020 |
Why?
|
| Pyruvates | 2 | 1980 | 28 | 0.020 |
Why?
|
| Glycolysis | 2 | 2005 | 519 | 0.020 |
Why?
|
| Age Factors | 2 | 1999 | 5377 | 0.020 |
Why?
|
| Dwarfism, Pituitary | 1 | 1990 | 8 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2017 | 2218 | 0.020 |
Why?
|
| Palmitates | 2 | 1991 | 23 | 0.020 |
Why?
|
| Somatomedins | 1 | 1990 | 75 | 0.020 |
Why?
|
| Apolipoproteins | 1 | 1990 | 75 | 0.020 |
Why?
|
| Benzoates | 1 | 1990 | 136 | 0.020 |
Why?
|
| Double-Blind Method | 3 | 2005 | 2588 | 0.020 |
Why?
|
| Hyperinsulinism | 2 | 1996 | 85 | 0.020 |
Why?
|
| Blood Proteins | 1 | 1990 | 294 | 0.020 |
Why?
|
| Radioactive Tracers | 1 | 1989 | 30 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2013 | 945 | 0.020 |
Why?
|
| HIV Infections | 1 | 2001 | 2134 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 1989 | 355 | 0.020 |
Why?
|
| Health Behavior | 1 | 2013 | 603 | 0.020 |
Why?
|
| Autoantibodies | 1 | 1992 | 576 | 0.020 |
Why?
|
| Mathematics | 3 | 1987 | 136 | 0.020 |
Why?
|
| Ion Exchange | 1 | 1988 | 8 | 0.020 |
Why?
|
| Hindlimb | 2 | 1986 | 105 | 0.020 |
Why?
|
| Quality Control | 1 | 1989 | 457 | 0.020 |
Why?
|
| Neoplasms | 1 | 2014 | 15193 | 0.020 |
Why?
|
| Physical Fitness | 2 | 2003 | 122 | 0.020 |
Why?
|
| Differential Threshold | 1 | 1987 | 14 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 1987 | 97 | 0.020 |
Why?
|
| Heart Defects, Congenital | 1 | 1979 | 1697 | 0.020 |
Why?
|
| Triglycerides | 3 | 1993 | 603 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2020 | 6869 | 0.020 |
Why?
|
| Hyperglycemia | 4 | 1985 | 333 | 0.020 |
Why?
|
| Decarboxylation | 1 | 1986 | 6 | 0.020 |
Why?
|
| Adaptation, Biological | 1 | 1987 | 49 | 0.020 |
Why?
|
| Breast Feeding | 1 | 1988 | 239 | 0.020 |
Why?
|
| Computational Biology | 1 | 2013 | 1271 | 0.020 |
Why?
|
| Stereoisomerism | 1 | 1986 | 164 | 0.020 |
Why?
|
| Environmental Pollutants | 1 | 2007 | 83 | 0.020 |
Why?
|
| Forelimb | 1 | 1986 | 25 | 0.020 |
Why?
|
| Genes | 2 | 1990 | 491 | 0.020 |
Why?
|
| Extracellular Space | 1 | 1986 | 132 | 0.020 |
Why?
|
| Glucose Clamp Technique | 2 | 1999 | 89 | 0.020 |
Why?
|
| Myosins | 1 | 1986 | 96 | 0.020 |
Why?
|
| Thiamine | 1 | 1985 | 11 | 0.020 |
Why?
|
| Threonine | 1 | 1986 | 161 | 0.020 |
Why?
|
| Precision Medicine | 1 | 2013 | 1154 | 0.020 |
Why?
|
| Diabetic Ketoacidosis | 3 | 1976 | 136 | 0.020 |
Why?
|
| Powders | 1 | 2005 | 23 | 0.020 |
Why?
|
| Riboflavin | 1 | 2005 | 26 | 0.020 |
Why?
|
| Selenium | 1 | 2005 | 47 | 0.020 |
Why?
|
| Occupational Health Services | 1 | 2004 | 13 | 0.020 |
Why?
|
| Neutron Activation Analysis | 1 | 1984 | 7 | 0.020 |
Why?
|
| Vitamin E | 1 | 2005 | 136 | 0.020 |
Why?
|
| Blood | 2 | 1995 | 156 | 0.020 |
Why?
|
| Phentolamine | 1 | 1983 | 26 | 0.020 |
Why?
|
| Acetylcysteine | 1 | 2005 | 143 | 0.020 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 1983 | 15 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 1989 | 624 | 0.020 |
Why?
|
| School Health Services | 1 | 2004 | 109 | 0.020 |
Why?
|
| Prospective Studies | 3 | 2005 | 12873 | 0.010 |
Why?
|
| Malawi | 1 | 2005 | 378 | 0.010 |
Why?
|
| Fibroblasts | 2 | 1988 | 1682 | 0.010 |
Why?
|
| Zinc | 1 | 1984 | 188 | 0.010 |
Why?
|
| Family Health | 1 | 2004 | 325 | 0.010 |
Why?
|
| Glycogen | 1 | 1983 | 80 | 0.010 |
Why?
|
| Community Health Services | 1 | 2004 | 126 | 0.010 |
Why?
|
| Digestive System Physiological Phenomena | 1 | 1983 | 9 | 0.010 |
Why?
|
| Calorimetry | 1 | 2003 | 62 | 0.010 |
Why?
|
| Activation Analysis | 1 | 1982 | 1 | 0.010 |
Why?
|
| Actins | 1 | 1986 | 608 | 0.010 |
Why?
|
| Absorption | 1 | 1982 | 81 | 0.010 |
Why?
|
| Breath Tests | 3 | 1992 | 177 | 0.010 |
Why?
|
| Galactosephosphates | 1 | 1982 | 4 | 0.010 |
Why?
|
| UTP-Hexose-1-Phosphate Uridylyltransferase | 1 | 1982 | 5 | 0.010 |
Why?
|
| Carnitine | 1 | 1983 | 94 | 0.010 |
Why?
|
| Puberty | 1 | 2003 | 104 | 0.010 |
Why?
|
| Health Education | 1 | 2004 | 309 | 0.010 |
Why?
|
| Absorptiometry, Photon | 1 | 2003 | 239 | 0.010 |
Why?
|
| Metabolism, Inborn Errors | 1 | 1983 | 108 | 0.010 |
Why?
|
| Spleen | 3 | 1992 | 676 | 0.010 |
Why?
|
| Health Policy | 1 | 2004 | 291 | 0.010 |
Why?
|
| Biomarkers | 1 | 2013 | 5047 | 0.010 |
Why?
|
| DNA | 1 | 1990 | 2693 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1982 | 629 | 0.010 |
Why?
|
| Radioimmunoassay | 3 | 1991 | 191 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 1984 | 492 | 0.010 |
Why?
|
| Lipids | 1 | 2005 | 644 | 0.010 |
Why?
|
| Hemiterpenes | 1 | 1980 | 6 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2001 | 227 | 0.010 |
Why?
|
| Blood Viscosity | 1 | 1980 | 23 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1982 | 339 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2005 | 32848 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2003 | 417 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 1990 | 6150 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2007 | 1399 | 0.010 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2001 | 234 | 0.010 |
Why?
|
| Cholesterol | 2 | 1993 | 658 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 2 | 1980 | 960 | 0.010 |
Why?
|
| Methods | 1 | 1979 | 189 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2001 | 980 | 0.010 |
Why?
|
| Least-Squares Analysis | 1 | 1999 | 66 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1988 | 5637 | 0.010 |
Why?
|
| Catecholamines | 2 | 1992 | 101 | 0.010 |
Why?
|
| Heart Rate | 3 | 1992 | 737 | 0.010 |
Why?
|
| Drug Stability | 1 | 1979 | 105 | 0.010 |
Why?
|
| Thyrotropin-Releasing Hormone | 1 | 1978 | 20 | 0.010 |
Why?
|
| Crohn Disease | 1 | 1982 | 351 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2004 | 732 | 0.010 |
Why?
|
| Biological Transport, Active | 2 | 1990 | 131 | 0.010 |
Why?
|
| Lipid Mobilization | 1 | 1977 | 4 | 0.010 |
Why?
|
| Young Adult | 1 | 2016 | 21445 | 0.010 |
Why?
|
| Phosphorylation | 2 | 1996 | 4804 | 0.010 |
Why?
|
| Transplantation, Autologous | 2 | 1992 | 1914 | 0.010 |
Why?
|
| Complement System Proteins | 1 | 1978 | 139 | 0.010 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 1978 | 167 | 0.010 |
Why?
|
| 3-O-Methylglucose | 1 | 1996 | 1 | 0.010 |
Why?
|
| Methylglucosides | 1 | 1996 | 2 | 0.010 |
Why?
|
| Radioisotopes | 1 | 1977 | 177 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2004 | 2203 | 0.010 |
Why?
|
| HIV-1 | 1 | 2001 | 653 | 0.010 |
Why?
|
| Prevalence | 1 | 2004 | 3260 | 0.010 |
Why?
|
| Mannitol | 1 | 1996 | 54 | 0.010 |
Why?
|
| Blood Urea Nitrogen | 2 | 1986 | 95 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 1977 | 305 | 0.010 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 1995 | 153 | 0.010 |
Why?
|
| Central Nervous System | 1 | 1977 | 436 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 1996 | 276 | 0.010 |
Why?
|
| Splanchnic Circulation | 1 | 1993 | 53 | 0.010 |
Why?
|
| Citrate (si)-Synthase | 1 | 1992 | 21 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2001 | 4988 | 0.010 |
Why?
|
| Mitochondria, Muscle | 1 | 1992 | 50 | 0.010 |
Why?
|
| Feedback | 1 | 1993 | 198 | 0.010 |
Why?
|
| Insulin Antibodies | 1 | 1972 | 7 | 0.010 |
Why?
|
| Apolipoprotein B-100 | 1 | 1992 | 30 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1992 | 329 | 0.010 |
Why?
|
| Diabetic Nephropathies | 1 | 1974 | 183 | 0.010 |
Why?
|
| Body Temperature Regulation | 1 | 1991 | 38 | 0.010 |
Why?
|
| Pulmonary Gas Exchange | 1 | 1991 | 41 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2001 | 6009 | 0.010 |
Why?
|
| Autoimmunity | 1 | 1992 | 263 | 0.010 |
Why?
|
| Citric Acid Cycle | 1 | 1990 | 86 | 0.010 |
Why?
|
| DNA Restriction Enzymes | 1 | 1990 | 117 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 1996 | 2292 | 0.010 |
Why?
|
| Portal Vein | 1 | 1992 | 355 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1990 | 130 | 0.010 |
Why?
|
| gamma-Globulins | 1 | 1969 | 21 | 0.010 |
Why?
|
| Arm | 1 | 1990 | 147 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1990 | 406 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1993 | 850 | 0.010 |
Why?
|
| Ataxia Telangiectasia | 1 | 1969 | 62 | 0.010 |
Why?
|
| Perception | 1 | 1991 | 350 | 0.010 |
Why?
|
| Peptides | 1 | 1975 | 1479 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1989 | 573 | 0.010 |
Why?
|
| Intubation, Gastrointestinal | 1 | 1988 | 79 | 0.010 |
Why?
|
| Pancreatectomy | 1 | 1992 | 652 | 0.000 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 1969 | 238 | 0.000 |
Why?
|
| Biological Availability | 1 | 1987 | 214 | 0.000 |
Why?
|
| Milk | 1 | 1987 | 120 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2003 | 7702 | 0.000 |
Why?
|
| Chromosome Mapping | 1 | 1990 | 1471 | 0.000 |
Why?
|
| Exons | 1 | 1990 | 1328 | 0.000 |
Why?
|
| Blood Transfusion | 1 | 1969 | 583 | 0.000 |
Why?
|
| Depression, Chemical | 2 | 1976 | 52 | 0.000 |
Why?
|
| Ketone Oxidoreductases | 1 | 1985 | 4 | 0.000 |
Why?
|
| 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) | 1 | 1985 | 12 | 0.000 |
Why?
|
| Cattle | 1 | 1987 | 783 | 0.000 |
Why?
|
| Amination | 1 | 1984 | 2 | 0.000 |
Why?
|
| Kidney Tubules | 1 | 1985 | 137 | 0.000 |
Why?
|
| Deamination | 1 | 1984 | 13 | 0.000 |
Why?
|
| Triiodothyronine | 1 | 1984 | 77 | 0.000 |
Why?
|
| Ammonia | 1 | 1984 | 88 | 0.000 |
Why?
|
| Multienzyme Complexes | 1 | 1985 | 213 | 0.000 |
Why?
|
| Models, Chemical | 1 | 1984 | 186 | 0.000 |
Why?
|
| Polymorphism, Genetic | 1 | 1990 | 1450 | 0.000 |
Why?
|
| Twins, Dizygotic | 1 | 1983 | 49 | 0.000 |
Why?
|
| Pituitary Function Tests | 1 | 1982 | 8 | 0.000 |
Why?
|
| Propranolol | 1 | 1983 | 156 | 0.000 |
Why?
|
| Thyroid Function Tests | 1 | 1982 | 38 | 0.000 |
Why?
|
| Food, Formulated | 1 | 1982 | 50 | 0.000 |
Why?
|
| NAD | 1 | 1982 | 89 | 0.000 |
Why?
|
| NADP | 1 | 1982 | 96 | 0.000 |
Why?
|
| Muscle Hypotonia | 1 | 1983 | 180 | 0.000 |
Why?
|
| Drug Interactions | 1 | 1983 | 553 | 0.000 |
Why?
|
| Monocytes | 1 | 1985 | 788 | 0.000 |
Why?
|
| Exchange Transfusion, Whole Blood | 1 | 1980 | 13 | 0.000 |
Why?
|
| Hematocrit | 1 | 1980 | 142 | 0.000 |
Why?
|
| Sheep | 1 | 1980 | 258 | 0.000 |
Why?
|
| Pregnancy in Diabetics | 1 | 1980 | 26 | 0.000 |
Why?
|
| Enteral Nutrition | 1 | 1982 | 316 | 0.000 |
Why?
|
| Syndrome | 1 | 1982 | 1351 | 0.000 |
Why?
|
| Analysis of Variance | 1 | 1983 | 2307 | 0.000 |
Why?
|
| Sex Factors | 1 | 1984 | 2139 | 0.000 |
Why?
|
| Aged, 80 and over | 2 | 1989 | 29902 | 0.000 |
Why?
|
| Risk | 1 | 1983 | 1972 | 0.000 |
Why?
|
| Liver Diseases | 1 | 1983 | 574 | 0.000 |
Why?
|
| Cardiomyopathies | 1 | 1983 | 610 | 0.000 |
Why?
|
| Animals, Newborn | 1 | 1980 | 1338 | 0.000 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 1975 | 242 | 0.000 |
Why?
|
| Iodine Isotopes | 1 | 1972 | 11 | 0.000 |
Why?
|
| Ketones | 1 | 1972 | 54 | 0.000 |
Why?
|
| Mutation | 1 | 1990 | 15179 | 0.000 |
Why?
|
| Long-Term Care | 1 | 1969 | 83 | 0.000 |
Why?
|
| Immunoglobulins | 1 | 1969 | 266 | 0.000 |
Why?
|
| Sinusitis | 1 | 1969 | 131 | 0.000 |
Why?
|
| Respiratory Tract Infections | 1 | 1969 | 437 | 0.000 |
Why?
|
| Tissue Donors | 1 | 1969 | 769 | 0.000 |
Why?
|
| Bone Marrow Transplantation | 1 | 1969 | 1581 | 0.000 |
Why?
|